After 100 days in office, President Donald Trump is presenting a summary of his work and announcing new initiatives, ...

Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the need for a multidisciplinary approach to translate the study's findings into real-world ...